China Cord Blood Corporation operates within the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Cord Blood with three other
health care providers in Asia:
Cedar Company Ltd
sales of 12.73 billion Japanese Yen [US$114.60 million]
of which 66%
was Facility Service),
Indraprastha Medical Corporation Limited
(7.66 billion Indian Rupees [US$118.92 million]
Kovai Medical Center And Hospital Limited
based in India
(5.26 billion Indian Rupees [US$81.63 million]
During the year ended March of 2017, sales at
China Cord Blood were 759.98 million Chinese Renmimbi (US$112.31 million).
increase of 14.6%
versus 2016, when the company's sales were 663.00 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Cord Blood
(and since 2012, sales have increased a total of 100%).